Siro Clinpharm Pvt
Siro Clinpharm Pvt. is a prominent clinical research organisation headquartered in India, with a strong operational presence across various regions. Established in 2005, the company has made significant strides in the pharmaceutical and biotechnology sectors, specialising in clinical trial management, regulatory affairs, and data management services. Siro Clinpharm is recognised for its commitment to quality and innovation, offering tailored solutions that enhance the efficiency of clinical development processes. With a diverse portfolio of services, the company has positioned itself as a trusted partner for global pharmaceutical companies, contributing to numerous successful drug approvals. Notable achievements include a robust track record in conducting trials across multiple therapeutic areas, solidifying Siro Clinpharm's reputation as a leader in the clinical research industry.
DitchCarbon Score
How does Siro Clinpharm Pvt's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Siro Clinpharm Pvt's score of 0 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Siro Clinpharm Pvt's reported carbon emissions
Siro Clinpharm Pvt. Ltd., headquartered in India, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific carbon emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 emissions by 42% by 2030, using 2022 as the base year. This target has been validated through the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. Siro Clinpharm's commitment includes not only the reduction of direct emissions (Scope 1) and indirect emissions from energy consumption (Scope 2) but also a pledge to measure and address its Scope 3 emissions, which encompass the broader supply chain impacts. This comprehensive approach reflects the company's dedication to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. As a small to medium enterprise, Siro Clinpharm's initiatives demonstrate a proactive stance in tackling climate change, contributing to a more sustainable future while adhering to industry standards for environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Siro Clinpharm Pvt is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
